Grey Wolf Therapeutics
Clinical trials sponsored by Grey Wolf Therapeutics, explained in plain language.
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new experimental drug called GRWD5769, alone or with other cancer treatments, in people with advanced solid tumors that have not responded to standard therapy. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 30…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New pill aims to tame back and joint inflammation
Disease control Recruiting nowThis study tests an experimental pill called GRWD0715 for people with axial spondyloarthritis, a condition that causes long-term inflammation in the spine and pelvic joints. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduce…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC